Total Payments
$213,369
2024 Payments
$1,883
Companies
56
Transactions
923
Medicare Patients
7,063
Medicare Billing
$950,479
Payment Breakdown by Category
Other$168,825 (79.1%)
Travel$21,267 (10.0%)
Food & Beverage$15,146 (7.1%)
Consulting$8,075 (3.8%)
Education$55.76 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $166,825 | 70 | 78.2% |
| Travel and Lodging | $21,267 | 81 | 10.0% |
| Food and Beverage | $15,146 | 761 | 7.1% |
| Consulting Fee | $8,075 | 3 | 3.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,000 | 1 | 0.9% |
| Education | $55.76 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Depomed, Inc. | $96,660 | 145 | $0 (2017) |
| Daiichi Sankyo Inc. | $69,829 | 86 | $0 (2019) |
| West Therapeutics Development, LLC | $16,670 | 21 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $11,649 | 15 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,221 | 92 | $0 (2024) |
| ASSERTIO THERAPEUTICS, Inc. | $2,598 | 8 | $0 (2019) |
| PFIZER INC. | $2,004 | 63 | $0 (2024) |
| INSYS Therapeutics Inc | $1,767 | 4 | $0 (2017) |
| Nevro Corp. | $1,347 | 71 | $0 (2024) |
| ABBVIE INC. | $930.32 | 57 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,883 | 87 | Nalu Medical, Inc. ($422.98) |
| 2023 | $1,080 | 65 | ABBVIE INC. ($390.34) |
| 2022 | $932.59 | 29 | Medtronic, Inc. ($527.36) |
| 2021 | $1,036 | 77 | Collegium Pharmaceutical, Inc. ($197.26) |
| 2020 | $1,204 | 73 | Abbott Laboratories ($253.24) |
| 2019 | $14,394 | 147 | West Therapeutics Development, LLC ($10,086) |
| 2018 | $25,395 | 104 | Daiichi Sankyo Inc. ($15,073) |
| 2017 | $167,446 | 341 | Depomed, Inc. ($96,660) |
All Payment Transactions
923 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.49 | General |
| Category: Opioid Analgesic | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $66.93 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/22/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Pain Management | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Electronic Waveform Lab, Inc. | — | Food and Beverage | Cash or cash equivalent | $6.80 | General |
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $8.29 | General |
| Category: Opioid Analgesic | ||||||
| 10/21/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: Opioid Analgesic | ||||||
| 10/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Neuromodulation | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.45 | General |
| Category: Opioid Analgesic | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: General - Pain Management_NMD | ||||||
| 09/10/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $137.65 | General |
| Category: Pain Management | ||||||
| 09/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: PAIN | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.42 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/28/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,333 | 2,389 | $679,464 | $168,017 |
| 2022 | 21 | 1,888 | 3,583 | $1.1M | $259,497 |
| 2021 | 23 | 2,114 | 4,646 | $1.1M | $323,943 |
| 2020 | 25 | 1,728 | 2,843 | $810,031 | $199,023 |
Total Patients
7,063
Total Services
13,461
Medicare Billing
$950,479
Procedure Codes
99
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 277 | 559 | $204,594 | $48,718 | 23.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 171 | 305 | $121,344 | $30,566 | 25.2% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 58 | 69 | $52,239 | $13,072 | 25.0% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 117 | 206 | $33,884 | $8,468 | 25.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $28,560 | $6,893 | 24.1% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 31 | 36 | $25,116 | $6,423 | 25.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 42 | 70 | $24,639 | $6,263 | 25.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 46 | 77 | $23,485 | $5,949 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 43 | $22,059 | $5,364 | 24.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 74 | 88 | $16,368 | $5,107 | 31.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 38 | 54 | $15,228 | $3,930 | 25.8% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 55 | 63 | $14,703 | $3,778 | 25.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 23 | 35 | $13,950 | $3,506 | 25.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 39 | 67 | $13,359 | $3,437 | 25.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 22 | 62 | $10,850 | $2,599 | 24.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 25 | 36 | $10,665 | $2,439 | 22.9% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 29 | 33 | $8,118 | $2,127 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 37 | $9,546 | $2,032 | 21.3% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 23 | 34 | $7,735 | $1,937 | 25.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 33 | $7,400 | $1,812 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,760 | $1,467 | 25.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 22 | 28 | $3,677 | $793.73 | 21.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 16 | 19 | $2,869 | $717.78 | 25.0% |
| 77002 | Fluoroscopic guidance for needle placement | Facility | 2023 | 16 | 21 | $1,638 | $354.96 | 21.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 39 | 336 | $1,680 | $263.40 | 15.7% |
About Dr. Jerome Grove, MD
Dr. Jerome Grove, MD is a Specialist healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932153236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerome Grove, MD has received a total of $213,369 in payments from pharmaceutical and medical device companies, with $1,883 received in 2024. These payments were reported across 923 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($166,825).
As a Medicare-enrolled provider, Grove has provided services to 7,063 Medicare beneficiaries, totaling 13,461 services with total Medicare billing of $950,479. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Interventional Pain Medicine
- Location Phoenix, AZ
- Active Since 05/20/2006
- Last Updated 02/19/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932153236
Products in Payments
- Nucynta (Drug) $85,070
- Movantik (Drug) $48,848
- Lazanda (Drug) $23,643
- Morphabond ER (Drug) $21,040
- MOVANTIK (Drug) $11,649
- Gralise (Drug) $7,200
- RELISTOR (Drug) $3,094
- SUBSYS (Drug) $1,767
- EMBEDA (Drug) $1,430
- Senza Spinal Cord Stimulation System (Device) $1,315
- BOTOX (Biological) $838.38
- XTAMPZA (Drug) $591.10
- INTELLIS ADAPTIVESTIM (Device) $515.62
- Nalu Neurostimulation System (Device) $465.14
- NURTEC ODT (Drug) $374.51
- RELISTOR ORAL (Drug) $292.37
- Proclaim Family of SCS IPGs (Device) $268.84
- Evoke (Device) $262.41
- PROCLAIM (Device) $223.16
- LYRICA (Drug) $222.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Phoenix
Dr. Anthony Yeung
Specialist — Payments: $16.8M
Specialist $16.8M
Christopher Yeung, M.d, M.D
Specialist — Payments: $3.6M
Specialist $3.6M
Dr. John Mulcahy, M.d, M.D
Specialist — Payments: $1.2M
Specialist $1.2M
Eric Eross, Do, DO
Specialist — Payments: $971,598
Specialist $971,598
Dr. Richard Dolinar, M.d, M.D
Specialist — Payments: $721,885
Specialist $721,885
Dr. Norman Chutkan, M.d, M.D
Specialist — Payments: $184,959
Specialist $184,959